Description
As a consequence of the review, authorization and oversight of COVID-19 drugs under the Regulations, manufacturers may benefit from intellectual property protections that are available in respect of a submission that results in an NOC.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Intellectual property | HTML | Open resource | |
| Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Intellectual property | HTML | Open resource |